[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mood-disorder-depressive-episodes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mood-disorder-depressive-episodes":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100599658",false,"NCT07087353","Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes","A Randomized Controlled Trial Assessing the Efficacy of Remote Patient Monitoring in Patients Treated for a Moderate to Severe Major Depressive Episode","EC-102","Inclusion Criteria:\n\n* Adults (≥18 years old) meeting ICD-11 criteria for a moderate to severe major depressive episode\n* Access to a personal smartphone and an internet connection, and cognitively able to use it independently\n\nExclusion Criteria:\n\n* Pregnant women\n* Individuals under legal guardianship or conservatorship\n* Ongoing alcohol or drug abuse considered likely to interfere with study participation, as judged by the investigator\n* Psychiatric or physical comorbidities (e.g., severe neurological or cardiovascular conditions) considered likely to interfere with participation or study results, at the discretion of the Principal Investigator","ALL","18 Years",{"count":19,"type":20},594,"ESTIMATED","INTERVENTIONAL",[23],"NA","Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual care on symptoms, quality of life, healthcare costs, comorbidities, and user adherence and satisfaction.",[26],"Mood Disorder (Depressive Episodes)","RECRUITING","2026-04-27",{"date":30,"type":31},"2026-05-01","ACTUAL",{"date":33,"type":31},"2025-10-31",{"date":35,"type":20},"2027-12-01",{"name":37,"class":38},"Resilience","INDUSTRY",6,""]